Theratechnologies Inc.
Biotechnology
Healthcare
THTX
50.40 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.32
52 week high
3.31
high
3.33
52 week low
0.00
low
3.31
growth
166.94 %
previous Close
3.31
P/E ratio
market cap
147 M
div yield
0
usd
Feb 2025
qoq
revenue
19.05 M
-23.82 %
net incoming
117 K
101.48 %
eps
0.00 %
101.00 %
eps surprise
-94.65 %
net profit margin
0.61 %
32.00 %
operating incoming
1.90 M
106.20 %
net change in cash
-11.99 M
36.17 %
cash on hand
3.91 M
-33.80 %
cost of revenue
3.48 M
-42.86 %
top top